Metamizol Vir

Metamizole magnesium, the active ingredient in Metamizol Vir, is a pyrazolone presented as an oral formulation for oral use. It provides analgesic and antipyretic effects for the relief of pain and fever in adults.

GNH USA supplies Metamizol Vir as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole Vir is a pyrazolone that acts on prostaglandin synthesis pathways to relieve pain and reduce fever. - Pain: alleviates moderate to severe acute pain such as postoperative or trauma‑related discomfort. - Fever: reduces elevated body temperature associated with infectious or inflammatory conditions. - Cancer‑related pain: offers additional analgesia when conventional opioids are insufficient.

Metamizol Vir may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional episodes after dosing. - Dizziness: transient light‑headedness. - Hypotension: drop in blood pressure, especially with rapid IV administration. - Skin rash: mild erythema or itching. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in white blood cells, risk of infection. - Anaphylactic reaction: sudden severe allergic response. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Hepatotoxicity: significant liver injury. - Hemolytic anemia: destruction of red blood cells. - Severe hypotension: potentially life‑threatening blood pressure fall.

Before prescribing Metamizol Vir, consider the following safety measures. - Blood count monitoring: perform baseline and periodic leukocyte counts to detect agranulocytosis. - Hypersensitivity assessment: avoid use in patients with known allergy to pyrazolones. - Renal/hepatic impairment: use cautiously and adjust dosing if organ dysfunction is present. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Concomitant myelosuppressive therapy: increase vigilance for bone‑marrow suppression. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metamizol Vir can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Cytotoxic chemotherapy agents: may amplify bone‑marrow suppression. - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Sulfonamide antibiotics: potential cross‑reactivity leading to hypersensitivity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive hypotensive effect. - Diuretics: may affect renal clearance and electrolyte balance. - Lithium: possible increase in lithium serum levels. - Other NSAIDs: heightened risk of gastrointestinal irritation. - Corticosteroids: may enhance risk of gastrointestinal ulceration.